One month after placing executives on leave, Chemours has updated its financials. The company is also fielding information requests from prosecutors and regulators.
Chemours has tapped Denise Dignam as its next leader, within a month of placing President and CEO Mark Newman and other financial executives on leave.
Chemours’ internal audit has found that three executives, including CEO Mark Newman, violated the company’s ethics code to alter the appearance of cash flow targets dating back to the end of 2022.
Looking into weaknesses in internal controls on financial reporting, Chemours has placed top leaders on administrative leave.
WILMINGTON – As it continues to pare its existing business lines to adjust for future target industries, Chemours has reached a sale agreement for its glycolic acid business worth $137 […]
Premier Digital Partners
© 2024 Delaware Business Times
